INTERPARFUMS INC 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2021 . OR ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ______to _____. Commission File No. 0-16469 INTER PARFUMS, INC . (Exact name of registrant as specified in its charter) Delaware 13-3275609 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 551 Fifth Avenue , New York , New York 10176 (Address of Principal Executive Offices) (Zip Code) ( 212 ) 983-2640 (Registrants telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.001 par value per share IPAR The Nasdaq Stock Market Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act). Large accelerated Filer ☒ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging Growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. At May 10, 2021, there were 31,652,038 shares of common stock, par value $.001 per share, outstanding. INTER PARFUMS, INC. AND SUBSIDIARIES INDEX Page Number Part I. Financial Information 1 Item 1. Financial Statements 1 Consolidated Balance Sheets as of March 31, 2021 and December 31, 2020 2 Consolidated Statements of Income for the Three Months Ended March 31, 2021 and March 31, 2020 3 Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2021 and March 31, 2020 4 Consolidated Statements of Changes in Equity for the Three Months Ended March 31, 2021 and March 31, 2020 5 Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2021 and March 31, 2020 6 Notes to Consolidated Financial Statements 7 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 15 Item 3. Quantitative and Qualitative Disclosures About Market Risk 25 Item 4. Controls and Procedures 26 Part II. Other Information 26 Item 6. Exhibits 27 Signatures 28 i INTER PARFUMS, INC. AND SUBSIDIARIES Part I. Financial Information Item 1. Financial Statements In our opinion, the accompanying unaudited consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary to present fairly our financial position, results of operations and cash flows for the interim periods presented. We have condensed such financial statements in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). Therefore, such financial statements do not include all disclosures required by accounting principles generally accepted in the United States of America. In preparing these consolidated financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through the date the consolidated financial statements were issued by filing with the SEC. These financial statements should be read in conjunction with our audited financial statements for the year ended December 31, 2020 included in our annual report filed on Form 10-K. The results of operations for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for the entire fiscal year. Page 1 INTER PARFUMS, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (In thousands except share and per share data) (Unaudited) March 31, 2021 December 31, 2020 ASSETS Current assets: Cash and cash equivalents $ 143,313 $ 169,681 Short-term investments 150,545 126,627 Accounts receivable, net 149,940 124,057 Inventories 148,685 158,822 Receivables, other 1,650 1,815 Other current assets 18,579 16,912 Income taxes receivable 404 2,806 Total current assets 613,116 600,720 Equipment and leasehold improvements, net 18,865 19,580 Right-of-use assets, net 22,807 24,734 Trademarks, licenses and other intangible assets, net 202,247 214,108 Deferred tax assets 7,669 8,041 Other assets 23,011 22,962 Total assets $ 887,715 $ 890,145 LIABILITIES AND EQUITY Current liabilities: Current portion of long-term debt $ 1,071 $ 14,570 Current portion of lease liabilities 4,983 5,133 Accounts payable – trade 44,680 35,576 Accrued expenses 88,600 95,629 Income taxes payable 12,774 5,297 Total current liabilities 152,108 156,205 Long–term debt, less current portion 9,173 10,136 Lease liabilities, less current portion 19,771 21,354 Equity: Inter Parfums, Inc. shareholders’ equity: Preferred stock, $ .001 par; authorized 1,000,000 shares; none issued -- -- Common stock, $ .001 par; authorized 100,000,000 shares; outstanding 31,652,038 and 31,608,588 shares at March 31, 2021 and December 31, 2020, respectively 32 32 Additional paid-in capital 77,566 75,708 Retained earnings 523,600 503,567 Accumulated other comprehensive loss ( 23,611 ) ( 5,997 ) Treasury stock, at cost, 9,864,805 shares at March 31, 2021 and December 31, 2020 ( 37,475 ) ( 37,475 ) Total Inter Parfums, Inc. shareholders’ equity 540,112 535,835 Noncontrolling interest 166,551 166,615 Total equity 706,663 702,450 Total liabilities and equity $ 887,715 $ 890,145 See notes to consolidated financial statements. Page 2 INTER PARFUMS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF INCOME (In thousands except per share data) (Unaudited) Three months ended March 31, 2021 2020 Net sales $ 198,528 $ 144,824 Cost of sales 73,280 55,783 Gross margin 125,248 89,041 Selling, general and administrative expenses 74,896 71,262 Impairment loss 2,393 -- Income from operations 47,959 17,779 Other expenses (income): Interest expense 377 1,001 Gain on foreign currency ( 1,866 ) ( 954 ) Interest income ( 386 ) ( 1,007 ) Other income ( 192 ) -- ( 2,067 ) ( 960 ) Income before income taxes 50,026 18,739 Income taxes 13,400 5,440 Net income 36,626 13,299 Less: Net income attributable to the noncontrolling interest 8,964 3,240 Net income attributable to Inter Parfums, Inc. $ 27,662 $ 10,059 Net income attributable to Inter Parfums, Inc. common shareholders: Basic $ 0.87 $ 0.32 Diluted $ 0.87 $ 0.32 Weighted average number of shares outstanding: Basic 31,631 31,530 Diluted 31,772 31,708 Dividends declared per share $ 0.25 $ 0.33 See notes to consolidated financial statements. Page 3 INTER PARFUMS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (In thousands) (Unaudited) Three months ended March 31, 2021 2020 Comprehensive income: Net income $ 36,626 $ 13,299 Other comprehensive income: Net derivative instrument gain (loss), net of tax ( 600 ) 257 Transfer from other comprehensive income into earnings -- ( 52 ) Translation adjustments, net of tax ( 26,119 ) ( 11,921 ) Comprehensive income 9,907 1,583 Comprehensive income attributable to the noncontrolling interests: Net income 8,964 3,240 Other comprehensive income: Net derivative instrument gain (loss), net of tax ( 164 ) 57 Translation adjustments, net of tax ( 8,941 ) ( 3,529 ) Comprehensive loss attributable to the noncontrolling interests ( 141 ) ( 232 ) Comprehensive income attributable to Inter Parfums, Inc. $ 10,048 $ 1,815 See notes to consolidated financial statements. Page 4 INTER PARFUMS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (In thousands) (Unaudited) Three months ended March 31, 2021 2020 Common stock, beginning and end of period $ 32 $ 31 Additional paid-in capital, beginning of period 75,708 70,664 Shares issued upon exercise of stock options 1,467 641 Share-based compensation 391 427 Transfer of subsidiary shares purchased -- 1,886 Additional paid-in capital, end of period 77,566 73,618 Retained earnings, beginning of period 503,567 474,637 Net income 27,662 10,059 Dividends ( 7,913 ) ( 10,406 ) Share-based compensation (adjustment) 284 ( 343 ) Retained earnings, end of period 523,600 473,947 Accumulated other comprehensive loss, beginning of period ( 5,997 ) ( 39,853 ) Foreign currency translation adjustment, net of tax ( 17,178 ) ( 8,392 ) Transfer from other comprehensive income into earnings -- ( 52 ) Net derivative instrument gain (loss), net of tax ( 436 ) 200 Accumulated other comprehensive loss, end of period ( 23,611 ) ( 48,097 ) Treasury stock, beginning and end of period ( 37,475 ) ( 37,475 ) Noncontrolling interest, beginning of period 166,615 140,994 Net income 8,964 3,240 Foreign currency translation adjustment, net of tax ( 8,941 ) ( 3,529 ) Net derivative instrument gain (loss), net of tax ( 164 ) 57 Share-based compensation (adjustment) ( 22 ) ( 34 ) Transfer of subsidiary shares purchased 99 ( 139 ) Dividends -- ( 324 ) Noncontrolling interest, end of period 166,551 140,265 Total equity $ 706,663 $ 602,289 See notes to consolidated financial statements. Page 5 INTER PARFUMS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) (Unaudited) Three months ended March 31, 2021 2020 Cash flows from operating activities: Net income $ 36,626 $ 13,299 Adjustments to reconcile net income to net cash used in operating activities: Depreciation and amortization 2,529 2,230 Provision for doubtful accounts 1,354 444 Noncash stock compensation 732 124 Share of income of equity investment ( 192 ) -- Impairment loss 2,393 -- Lease expense 236 19 Deferred tax provision (benefit) 58 ( 463 ) Change in fair value of derivatives 1,699 ( 170 ) Changes in: Accounts receivable ( 32,566 ) ( 4,545 ) Inventories 4,951 ( 4,702 ) Other assets ( 3,819 ) ( 3,545 ) Accounts payable and accrued expenses 8,102 ( 29,821 ) Income taxes, net 10,413 2,013 Net cash provided by (used in) operating activities 32,516 ( 25,117 ) Cash flows from investing activities: Purchases of short-term investments ( 30,367 ) ( 2,342 ) Purchases of equipment and leasehold improvements ( 1,205 ) ( 1,254 ) Payment for intangible assets acquired ( 302 ) ( 460 ) Net cash used in investing activities ( 31,874 ) ( 4,056 ) Cash flows from financing activities: Repayment of long-term debt ( 14,324 ) ( 6,577 ) Proceeds from exercise of options 1,467 641 Dividends paid ( 7,913 ) ( 10,399 ) Dividends paid to noncontrolling interest -- ( 324 ) Net cash used in financing activities ( 20,770 ) ( 16,659 ) Effect of exchange rate changes on cash ( 6,240 ) ( 4,028 ) Net decrease in cash and cash equivalents ( 26,368 ) ( 49,860 ) Cash and cash equivalents - beginning of period 169,681 133,417 Cash and cash equivalents - end of period $ 143,313 $ 83,557 Supplemental disclosure of cash flow information: Cash paid for: Interest $ 375 $ 462 Income taxes 2,861 3,706 See notes to consolidated financial statements. Page 6 INTER PARFUMS, INC. AND SUBSIDIARIES Notes to Consolidated Financial Statements 1. Significant Accounting Policies: The accounting policies we follow are set forth in the notes to our consolidated financial statements included in our Form 10-K, which was filed with the Securities and Exchange Commission for the year ended December 31, 2020. 2. Impact of COVID-19 Pandemic: A novel strain of coronavirus (“COVID-19”) surfaced in late 2019 and has spread around the world, including to the United States and France. In March 2020, the World Health Organization declared COVID-19 a pandemic. The COVID-19 pandemic disrupted our business operations and caused a significant unfavorable impact on our results of operations in 2020. In response to the COVID-19 pandemic various national, state, and local governments where we, our suppliers, and our customers operate initially issued decrees prohibiting certain businesses from continuing to operate and certain classes of workers from reporting to work. In all jurisdictions in which we operate we have been following guidance from authorities and health officials in allowing our teams to gradually return to our offices, including, requiring personnel to wear masks and implementing additional cleaning and sanitization routines at our offices and distribution centers. The effects of the COVID-19 pandemic on the beauty industry began in early March 2020. Retail store closings, event cancellations and a shutdown of international air travel brought our sales to a virtual standstill. Business significantly improved during the second half of 2020 and into the first quarter of 2021 as retail stores reopened and consumers increased their on-line purchasing and we expect this trend to continue. However, international travel has remained largely curtailed globally due to both government restrictions and consumer health concerns. In addition, the recent resurgence and introduction of variants of COVID-19 cases in various parts of the world have caused the temporary re-implementation of government restrictions to prevent further spread of the virus in certain jurisdictions. Therefore, despite recent business improvement, the impact of the COVID-19 pandemic may have a material adverse effect on our results of our operations, financial position and cash flows through at least the end of 2021. 3. Recent Agreements: Building Acquisition - Future Headquarters in Paris In April 2021, our majority owned Paris-based subsidiary, Interparfums SA, completed the acquisition of its future headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer, Apsys. This is an office complex combining three buildings connected by two inner courtyards, which consists of approximately 40,000 total sq. ft. The € 125 million (approximately $ 149 million) purchase price for this building, is in line with market values, includes the complete renovation of the site and is financed by a 10 -year € 120 million (approximately $ 143 million) bank loan to take advantage of low current interest rates. Page 7 INTER PARFUMS, INC. AND SUBSIDIARIES Notes to Consolidated Financial Statements Anna Sui Corp. In January 2021, we renewed our license agreement with Anna Sui Corp. for the creation, development and distribution of fragrance products through December 31, 2026, without any material changes in terms and conditions. Our initial 10-year license agreement with Anna Sui Corp. was signed in 2011. The renewal agreement also allows for an additional 5-year term through 2031 at the option of the Company. Rochas Fashion Effective January 1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, we have taken $ 2.4 million impairment charge on our Rochas fashion trademark. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value. 4. Recent Accounting Pronouncements: There are no recent accounting pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements. 5. Inventories: Inventories consist of the following: (In thousands) March 31, 2021 December 31, 2020 Raw materials and component parts $ 62,446 $ 66,492 Finished goods 86,239 92,330 $ 148,685 $ 158,822 Page 8 INTER PARFUMS, INC. AND SUBSIDIARIES Notes to Consolidated Financial Statements 6. Fair Value Measurement: The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Fair Value Measurements at March 31, 2021 Quoted Prices in Significant Other Significant Active Markets for Observable Unobservable Identical Assets Inputs Inputs Total (Level 1) (Level 2) (Level 3) Assets: Short-term investments $ 150,545 $ — $ 150,545 $ — Liabilities: Foreign currency forward exchange contracts accounted for using hedge accounting $ 597 $ — $ 597 $ — Foreign currency forward exchange contracts not accounted for using hedge accounting 815 — 815 — $ 1,412 $ — $ 1,412 $ — Fair Value Measurements at December 31, 2020 Quoted Prices in Significant Other Significant Active Markets for Observable Unobservable Identical Assets Inputs Inputs Total (Level 1) (Level 2) (Level 3) Assets: Short-term investments $ 126,627 $ — $ 126,627 $ — Foreign currency forward exchange contracts not accounted for using hedge accounting 253 — 253 — $ 126,880 $ — $ 126,880 $ — The carrying amount of cash and cash equivalents including money market funds, short-term investments, accounts receivable, other receivables, accounts payable and accrued expenses approximates fair value due to the short terms to maturity of these instruments. The carrying amount of loans payable approximates fair value as the interest rates on the Company’s indebtedness approximate current market rates. Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net present value of the swaps using third party quotes from financial institutions. Page 9 INTER PARFUMS, INC. AND SUBSIDIARIES Notes to Consolidated Financial Statements 7. Derivative Financial Instruments: The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings. Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income (loss) and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial for both three month periods ended March 31, 2021 and 2020. All derivative instruments are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of foreign currency forward exchange contracts at March 31, 2021, resulted in a liability and is included in accrued expenses on the accompanying balance sheet. At March 31, 2021, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. $ 78.5 million and GB £ 2.7 million which all have maturities of less than one year. 8. Leases: The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term. In determining lease asset value, the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available at the lease commencement date for the location in which the lease is held in determining the present value of lease payments. Page 10 INTER PARFUMS, INC. AND SUBSIDIARIES Notes to Consolidated Financial Statements As of March 31, 2021, the weighted average remaining lease term was 5.1 years and the weighted average discount rate used to determine the operating lease liability was 3.1 %. Rental expense related to operating leases was $ 1.4 million and $ 1.8 million for the periods ending March 31, 2021 and 2020, respectively. Operating lease payments included in operating cash flows totaled $ 1.5 million and $ 1.6 million for the three months ended March 31, 2021 and 2020, respectively, and noncash additions to operating lease assets totaled $ 0.0 million and $ 0.7 million for the three months ended March 31, 2021 and 2020, respectively. 9. Share-Based Payments: The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a four to five-year period. The fair value of shares vested during the three months ended March 31, 2021 and 2020 aggregated $ 0.09 million and $ 0.08 million, respectively. Compensation cost, net of forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. It is generally our policy to issue new shares upon exercise of stock options. The following table sets forth information with respect to nonvested options for the three month period ended March 31, 2021: Number of Shares Weighted Average Grant-Date Fair Value Nonvested options – beginning of period 353,790 $ 12.96 Nonvested options granted 9,000 $ 11.35 Nonvested options vested or forfeited ( 27,830 ) $ 12.96 Nonvested options – end of period 334,960 $ 12.91 Share-based payment expense decreased income before income taxes by $ 0.73 million and $ 0.12 million for the three months ended March 31, 2021 and 2020, respectively, and decreased net income attributable to Inter Parfums, Inc. by $ 0.49 million and $ 0.18 million for the three months ended March 31, 2021 and 2020. The following table summarizes stock option information as of March 31, 2021: Shares Weighted Average Exercise Price Outstanding at January 1, 2021 713,210 $ 52.74 Options granted 9,000 62.18 Options forfeited ( 28,320 ) 61.30 Options exercised ( 43,450 ) 33.77 Outstanding at March 31, 2021 650,440 $ 53.76 Options exercisable 315,480 $ 44.75 Options available for future grants 559,440 Page 11 INTER PARFUMS, INC. AND SUBSIDIARIES Notes to Consolidated Financial Statements As of March 31, 2021, the weighted average remaining contractual life of options outstanding is 3.19 years ( 2.49 years for options exercisable); the aggregate intrinsic value of options outstanding and options exercisable is $ 11.5 million and $ 8.3 million, respectively; and unrecognized compensation cost related to stock options outstanding aggregated $ 4.1 million. Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2021 and March 31, 2020 were as follows: (In thousands) March 31, 2021 March 31, 2020 Cash proceeds from stock options exercised $ 1,467 $ 641 Tax benefits 200 -- Intrinsic value of stock options exercised 1,457 733 The weighted average fair values of the options granted by Inter Parfums, Inc. during the three months ended March 31, 2021 and 2020 were $ 11.35 and $ 12.16 per share, respectively, on the date of grant using the Black-Scholes option pricing model to calculate the fair value of options granted. The assumptions used in the Black-Scholes pricing model for the periods ended March 31, 2021 and 2020 are set forth in the following table: March 31, 2021 March 31, 2020 Weighted average expected stock-price volatility 25 % 25 % Weighted average expected option life 5 years 5 years Weighted average risk-free interest rate 0.4 % 1.4 % Weighted average dividend yield 1.6 % 2.5 % Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors would increase as the earnings of the Company and its stock price continue to increase. In December 2018, Interparfums SA, our 73 % owned French subsidiary, approved a plan to grant an aggregate of 26,600 shares of its stock to employees with no performance condition requirement, and an aggregate of 133,000 shares to officers and managers, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2022. In order to avoid dilution of the Company’s ownership of Interparfums SA, all shares to be distributed pursuant to the plan will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA in prior years. In March 2020, due to the potential impact on future net sales and operating results resulting from the COVID-19 pandemic, the estimated number of shares to be distributed, after forfeited shares, was reduced from 142,571 to 82,162. As the Company had already purchased shares in contemplation of the higher anticipated distribution, shares purchased in excess of the reduced anticipated distribution were transferred to treasury shares at Interparfums SA level. Page 12 INTER PARFUMS, INC. AND SUBSIDIARIES Notes to Consolidated Financial Statements The fair value of the grant had been determined based on the quoted stock price of Interparfums SA shares as reported by the NYSE Euronext on the date of grant. The original cost of the grant was approximately $4.4 million, and the March 2020 revaluation resulted in a reduction of the cost, to approximately $2.5 million. In June 2020, the performance conditions were modified effecting 96 employees. As of March 31, 2021, the number of shares to be distributed, after forfeited shares, increased to 158,707 . The increase in shares anticipated to be distributed were transferred from treasury shares at the Interparfums SA level. The original cost of the grant was approximately $ 4.4 million, and the modification resulted in a revised cost of approximately $ 4.6 million. 10. Net Income Attributable to Inter Parfums, Inc. Common Shareholders: Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method. The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: Three months ended March 31, (In thousands, except per share data) 2021 2020 Numerator: Net income attributable to Inter Parfums, Inc. $ 27,662 $ 10,059 Denominator: Weighted average shares 31,631 31,530 Effect of dilutive securities: Stock options 141 178 Denominator for diluted earnings per share 31,772 31,708 Earnings per share: Net income attributable to Inter Parfums, Inc. common shareholders: Basic $ 0.87 $ 0.32 Diluted 0.87 0.32 Not included in the above computations is the effect of antidilutive potential common shares which consist of outstanding options to purchase 0.35 and 0.37 million shares of common stock for the three months ended March 31, 2021 and 2020, respectively. Page 13 INTER PARFUMS, INC. AND SUBSIDIARIES Notes to Consolidated Financial Statements 11. Segment and Geographic Areas: The Company manufactures and distributes one product line, fragrances and fragrance related products. The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. Both European operations and United States operations primarily represent the sale of prestige brand name fragrances. Information on our operations by geographical areas is as follows: (In thousands) Three months ended March 31, 2021 2020 Net sales: United States $ 39,196 $ 31,618 Europe 159,766 114,123 Eliminations ( 434 ) ( 917 ) $ 198,528 $ 144,824 Net income attributable to Inter Parfums, Inc.: United States $ 4,187 $ 1,606 Europe 23,475 8,453 $ 27,662 $ 10,059 March 31, December 31, 2021 2020 Total Assets: United States $ 140,875 $ 141,316 Europe 759,473 758,812 Eliminations of investment in subsidiary ( 12,633 ) ( 9,983 ) $ 887,715 $ 890,145 12. Reclassifications: Certain prior year’s amounts in the accompanying consolidated statements of cash flows have been reclassified to conform to current period presentation. Page 14 INTER PARFUMS, INC. AND SUBSIDIARIES Item 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Forward Looking Information Statements in this report which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions or expectations will be achieved. In some cases you can identify forward-looking statements by forward-looking words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” “will” and “would” or similar words. You should not rely on forward-looking statements because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings “Forward Looking Statements” and “Risk Factors” in Inter Parfums’ annual report on Form 10-K for the fiscal year ended December 31, 2020 and the reports Inter Parfums files from time to time with the Securities and Exchange Commission. Inter Parfums does not intend to and undertakes no duty to update the information contained in this report. Overview We operate in the fragrance business, and manufacture, market and distribute a wide array of fragrances and fragrance related products. We manage our business in two segments, European based operations and United States based operations. Certain prestige fragrance products are produced and marketed by our European operations through our 73% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 27% of Interparfums SA shares trade on the NYSE Euronext. We produce and distribute our European based fragrance products primarily under license agreements with brand owners, and European based fragrance product sales represented approximately 80% and 79% of net sales for the three months ended March 31, 2021 and 2020, respectively. We have built a portfolio of prestige brands, which include Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade New York, Lanvin, Moncler, Montblanc, Paul Smith, Repetto, Rochas, S.T. Dupont and Van Cleef & Arpels , whose products are distributed in over 120 countries around the world. Through our United States operations, we also market fragrance and fragrance related products. United States operations represented 20% and 21% of net sales for the three months ended March 31, 2021 and 2020, respectively. These fragrance products are sold primarily pursuant to license or other agreements with the owners of the Abercrombie & Fitch, Anna Sui, bebe, Dunhill, French Connection, Graff, GUESS, Hollister, MCM and Oscar de la Renta brands. Page 15 INTER PARFUMS, INC. AND SUBSIDIARIES Substantially all of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses. With respect to the Company’s largest brands, we license the Montblanc, Jimmy Choo, Coach and GUESS brand names. As a percentage of net sales, product sales for the Company’s largest brands were as follows: Three Months Ended March 31, 2021 2020 Montblanc. 20 % 21 % Jimmy Choo. 18 % 15 % Coach. 16 % 20 % GUESS. 10 % 11 % Quarterly sales fluctuations are influenced by the timing of new product launches as well as the third and fourth quarter holiday season. In certain markets where we sell directly to retailers, seasonality is more evident. We sell directly to retailers in France as well as through our own distribution subsidiaries in Spain and the United States. We grow our business in two distinct ways. First, we grow by adding new brands to our portfolio, either through new licenses or other arrangements or out-right acquisitions of brands. Second, we grow through the introduction of new products and by supporting new and established products through advertising, merchandising and sampling as well as phasing out underperforming products so we can devote greater resources to those products with greater potential. The economics of developing, producing, launching and supporting products influence our sales and operating performance each year. Our introduction of new products may have some cannibalizing effect on sales of existing products, which we take into account in our business planning. Our business is not capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general contractor and source our needed components from our suppliers. These components are received at one of our distribution centers and then, based upon production needs, the components are sent to one of several third party fillers, which manufacture the finished product for us and then deliver them to one of our distribution centers. As with any global business, many aspects of our operations are subject to influences outside our control. We believe we have a strong brand portfolio with global reach and potential. As part of our strategy, we plan to continue to make investments behind fast-growing markets and channels to grow market share. Our reported net sales are impacted by changes in foreign currency exchange rates. A strong U.S. dollar has a negative impact on our net sales. However, earnings are positively affected by a strong dollar, because almost 50% of net sales of our European operations are denominated in U.S. dollars, while almost all costs of our European operations are incurred in euro. Conversely, a weak U.S. dollar has a favorable impact on our net sales while gross margins are negatively affected. We address certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments and primarily enter into foreign currency forward exchange contracts to reduce the effects of fluctuating foreign currency exchange rates. Page 16 INTER PARFUMS, INC. AND SUBSIDIARIES Impact of COVID-19 Pandemic A novel strain of coronavirus (“COVID-19”) surfaced in late 2019 and has spread around the world, including to the United States and France. In March 2020, the World Health Organization declared COVID-19 a pandemic. The COVID-19 pandemic disrupted our business operations and caused a significant unfavorable impact on our results of operations in 2020. In response to the COVID-19 pandemic various national, state, and local governments where we, our suppliers, and our customers operate initially issued decrees prohibiting certain businesses from continuing to operate and certain classes of workers from reporting to work. In all jurisdictions in which we operate we have been following guidance from authorities and health officials in allowing our teams to gradually return to our offices, including, requiring personnel to wear masks and implementing additional cleaning and sanitization routines at our offices and distribution centers. The effects of the COVID-19 pandemic on the beauty industry began in early March 2020. Retail store closings, event cancellations and a shutdown of international air travel brought our sales to a virtual standstill. Beginning in June 2020, retail stores in many jurisdictions around the world began reopening and business has improved considerably. However, international travel has remained largely curtailed globally due to both government restrictions and consumer health concerns. Business significantly improved during the second half of 2020 and into the first quarter of 2021 as retail stores reopened and consumers increased their on-line purchasing, and we expect this trend to continue. However, the recent resurgence and introduction of variants of COVID-19 cases in various parts of the world has caused the temporary re-implementation of government restrictions to prevent further spread of the virus in certain jurisdictions. Therefore, despite recent business improvement, the impact of the COVID-19 pandemic may have a material adverse effect on our results of our operations, financial position and cash flows through at least the end of 2021. Operationally, we are prepared for increased demand in the post-COVID-19 environment, with business in most parts of the world showing signs of a comeback. We have geared up to rapidly fill the distribution channels as the crisis subsides. In that regard, we have maintained reasonable inventory levels of components and finished goods, and we are gaining local market intelligence from our distributors and production capacity data from our suppliers. Recent Important Events Building Acquisition - Future Headquarters in Paris In April 2021, our majority owned Paris-based subsidiary, Interparfums SA, completed the acquisition of its future headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer, Apsys. This is an office complex combining three buildings connected by two inner courtyards, a large part of which was the French Socialist Party’s former headquarters, which consists of approximately 40,000 total sq. ft. The €125 million (approximately $149 million) purchase price for this building, is in line with market values, includes the complete renovation of the site and is financed by a 10-year €120 million (approximately $143 million) bank loan to take advantage of low current interest rates. Page 17 INTER PARFUMS, INC. AND SUBSIDIARIES Anna Sui Corp. In January 2021, we renewed our license agreement with Anna Sui Corp. for the creation, development and distribution of fragrance products through December 31, 2026, without any material changes in terms and conditions. Our initial 10-year license agreement with Anna Sui Corp. was signed in 2011. The renewal agreement also allows for an additional 5-year term through 2031 at the option of the Company. Origines-Parfums In June 2020, the Company through its 73% owned subsidiary, Interparfums SA, and Divabox SAS (“Divabox”), owner of the Origines-parfums e-commerce platform for beauty products, signed a strategic agreement and equity investment pursuant to which we acquired 25% of Divabox capital for $14.0 million, through a capital increase. In connection with the acquisition, the Company entered into a $13.4 million term loan, which has been amended such that the loan was repaid in full in February 2021. As a website of reference for all selective fragrance brands, Origines-parfums is a key French player in the online beauty market recognized for its customer relationship expertise. This agreement should enhance the introduction of dedicated fragrance lines and products designed to address a specific consumer demand for this distribution channel and accelerate our digital development. Moncler In June 2020, the Company entered into an exclusive, 5-year worldwide license agreement with a potential 5-year extension with Moncler for the creation, development and distribution of fragrances under the Moncler brand. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. Moncler was founded at Monestier-de-Clermont, Grenoble, France, in 1952 and is currently headquartered in Italy. Over the years, the brand has combined style with constant technological research assisted by experts in activities linked to the world of the mountain. The Moncler outerwear collections marry the extreme demands of nature with those of city life. Our first fragrance launch for the Moncler brand is scheduled for the first quarter of 2022. Discussion of Critical Accounting Policies Information regarding our critical accounting policies can be found in our 2020 Annual Report on Form 10-K filed with the SEC. Page 18 INTER PARFUMS, INC. AND SUBSIDIARIES Results of Operations Three Months Ended March 31, 2021 as Compared to the Three Months Ended March 31, 2020 Net Sales Three months ended March 31, (in millions) 2021 % Change 2020 European based product sales $ 159.7 40.0 % $ 114.1 United States based product sales 38.8 26.2 % 30.7 Total net sales $ 198.5 37.1 % $ 144.8 Net sales for the three months ended March 31, 2021 increased 37.1% to $198.5 million, as compared to $144.8 million for the corresponding period of the prior year. At comparable foreign currency exchange rates, net sales increased 32.7%. For the 2021 first quarter, the average U.S. dollar/euro exchange rate was 1.20 as compared to 1.10 in the first quarter of 2020. European based product sales increased 40.0% to $159.7 million for the three months ended March 31, 2021, as compared to $114.1 million for the corresponding period of the prior year. At comparable foreign currency exchange rates, net sales increased 34.5%. Continuing the rebound that began in the second half of 2020, sales for the first three months of 2021 set a first quarter record. Not only were 2021 first quarter sales 37.1% ahead of the 2020 first quarter, but they were also 11.4% ahead of the 2019 first quarter sales of $178.2 million. Product sales for our largest brands within European operations, Montblanc, Jimmy Choo, Coach, and Lanvin, rose 27.5%, 66.7%, 8.8% and 91.2%, respectively. Montblanc legacy scents were responsible for the increase in brand sales, and the same holds for Lanvin fragrances with a major sales boost in the brand’s major markets, Eastern Europe and Asia. In 2021, the increase in Coach sales was more of a function of a weaker dollar rather than increased sales volume; in 2020 comparable quarter sales rose 35.9% over the 2019 first quarter due in great part to the pre-pandemic launch of Coach Dreams . The combination of the strong sales by established Jimmy Choo scents along with the first quarter launch of I Want Choo produced the gain in first quarter brand sales. Initial sales of Kate Spade New York , our first new fragrance for the brand, also pushed first quarter sales to a new record as did the launch of our eco-friendly scent, Rochas Girl. Page 19 INTER PARFUMS, INC. AND SUBSIDIARIES United States based product sales increased 26.2% to $38.8 million for the three months ended March 31, 2021, as compared to $30.7 million for the corresponding period of the prior year. With little exception, our U.S. brands also produced strong growth in the first quarter. GUESS, our largest brand, continued to benefit from a combination of legacy fragrance sales and initial distribution of Bella Vita . We have had strong replenishment orders for the Authentic Night duo by Abercrombie & Fitch which debuted late last year while first quarter shipments of the Canyon Escape duo drove Hollister brand sales growth. Debuting in limited distribution toward the end of the first quarter was our MCM signature scent, our first scent for this brand, with global rollout now underway. The first quarter decline in Anna Sui brand sales following the 62.3% increase in the 2020 fourth quarter, was primarily due to the launch of Sky in the 2020 fourth quarter. The limited duty free/travel retail market also factored into the decline in Anna Sui brand sales. However, we have significant Anna Sui open orders and look forward to improving brand sales as the year unfolds. Our newest Oscar de la Renta scent, Alibi , was unveiled late in the first quarter with broader distribution now in process. Net Sales to Customers by Region Three months ended March 31, (in millions) 2021 2020 North America $ 72.6 $ 46.5 Western Europe 45.2 41.4 Asia 30.1 22.5 Middle East 18.9 14.4 Eastern Europe 15.9 7.1 Central and South America 13.3 10.9 Other 2.5 2.0 $ 198.5 $ 144.8 Most regions showed gains, with sales by two of our three largest markets, North America and Asia, up 56% and 34%, respectively. The 9% reported sales increase in Western Europe was attributable to the weaker dollar, as the region was impacted by the lockdowns in the United Kingdom, Germany and Italy. Comparable quarter sales also bounced back in the Middle East, Eastern Europe and Central and South America, growing 31%, 125% and 22%, respectively. Gross Profit Margin Three months ended March 31, (in millions) 2021 2020 Net sales $ 198.5 $ 144.8 Cost of sales 73.3 55.8 Gross margin $ 125.2 $ 89.0 Gross margin as a % of net sales 63.1 % 61.5 % Gross profit margin was 63.1% of net sales for the three months ended March 31, 2021, as compared to 61.5% for the corresponding period of the prior year. For European operations, gross profit margin was 65.5% and 63.9% in the first quarters of 2021 and 2020, respectively. We carefully monitor movements in foreign currency exchange rates as almost 50% of our European based operations net sales are denominated in U.S. dollars, while most of our costs are incurred in euro. From a margin standpoint, a strong U.S. dollar has a positive effect on our gross profit margin while a weak U.S. dollar has a negative effect. For the three months ended March 31, 2021 the weaker dollar, as compared to the corresponding period of the prior year had a negative effect on gross margin. However, significantly reduced lower margin giftset sales in 2021 and new product launches with better margins mitigated the negative effect from currency exchange rates in the period. For U.S. operations, gross profit margin was 53.2% and 52.6% in the first quarters of 2021 and 2020, respectively. With the increase in sales in the first quarter of 2021, we were better able to absorb expenses such as depreciation of tools and molds and the cost of point-of-sale materials, as compared to the corresponding period of the prior year. Page 20 INTER PARFUMS, INC. AND SUBSIDIARIES Generally, we do not bill customers for shipping and handling costs and such costs, which aggregated $1.7 million and $1.6 million for the three months ended March 31, 2021 and 2020, respectively, and are included in selling, general and administrative expenses in the consolidated statements of income. As such, our Company’s gross profit may not be comparable to other companies which may include these expenses as a component of cost of goods sold. Selling, General and Administrative Expenses Three months ended March 31, (in millions) 2021 2020 Selling, general and administrative expenses $ 74.9 $ 71.3 Selling, general and administrative expenses as a % of net sales 37.7 % 49.2 % Selling, general and administrative expenses increased 5.1% for the three months ended March 31, 2021, as compared to the corresponding period of the prior year. As a percentage of sales, selling, general and administrative expenses were 37.7% and 49.2% for the three months ended March 31, 2021 and 2020, respectively. For European operations, with sales up 40.0%, selling, general and administrative expenses increased 3.9% in 2021, as compared to 2020 and represented 37.2% of sales in 2021, as compared to 50.1% of sales in 2020. For U.S. operations, with sales up 26.2%, selling, general and administrative expenses increased 9.9% in 2021 as compared to 2020 and represented 39.9% and 45.8% of sales in 2021 and 2020, respectively. The decline in selling, general and administrative expenses as a percentage of sales for the 2021 period was primarily due to lower promotional and advertising expenses. Sales rebounded more quickly than anticipated, and we did not have the opportunity to reinvest in additional promotion and advertising to match our historic levels. Promotion and advertising included in selling, general and administrative expenses aggregated approximately $21.8 million (11.0% of net sales) for the 2021 period, as compared to $28.5 million (19.7% of net sales) for the 2020 period. As the COVID-19 pandemic recedes, we plan to invest heavily in promotional spending to support new product launches and to build brand awareness. We have significant promotion and advertising programs planned for 2021 and expect promotion and advertising expense included in selling general and administrative expense to aggregate approximately 21% of sales for the full year ended December 31, 2021. Royalty expense included in selling, general and administrative expenses aggregated $15.4 million for the 2021 period, as compared to $11.3 million in 2020 and represented 7.7% and 7.8% of net sales in 2021 and 2020, respectively. As a result of the above analysis regarding sales, margins and selling, general and administrative expenses, income from operations increased 169.7% to $48.0 million for the three months ended March 31, 2021, as compared to $17.8 million for the corresponding period of the prior year. Operating margins were 24.2% of net sales in the current period as compared to 12.3% for the corresponding period of the prior year. Other Income and Expense Interest expense aggregated $0.4 million and $1.0 million for the three months ended March 31, 2021 and 2020, respectively. Interest expense is primarily related to the financing of brand and licensing acquisitions. We use the credit lines available to us, as needed, to finance our working capital needs as well as our financing needs for acquisitions. Page 21 INTER PARFUMS, INC. AND SUBSIDIARIES Foreign currency gains aggregated $1.9 million and $1.0 million for the three months ended March 31, 2021 and 2020, respectively. We typically enter into foreign currency forward exchange contracts to manage exposure related to receivables from unaffiliated third parties denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Almost 50% of net sales of our European operations are denominated in U.S. dollars. Interest income aggregated $0.4 million and $1.0 million for the three months ended March 31, 2021 and 2020, respectively. Cash and cash equivalents and short-term investments are primarily invested in certificates of deposit with varying maturities. Income Taxes Our effective tax rate was 26.8% and 29.0% for the three months ended March 31, 2021 and 2020, respectively. Pursuant to an action plan released by the French Prime Minister, the French corporate income tax rate is to be cut from 33% to 25% over the three-year period ending 2023. Our effective tax rate for European operations was 28% and 30% for the three months ended March 31, 2021 and 2020, respectively. Our effective tax rate for U.S. operations was 17.0% for the three months ended March 31, 2021, as compared to 20.9% for the corresponding period of the prior year. Our effective tax rate differs from the 21% statutory rate due to benefits received from the exercise of stock options as well as deductions we are allowed for a portion of our foreign derived intangible income slightly offset by state and local taxes. The benefit from the exercise of stock options for the three months ended March 31, 2021 was $0.2 million as compared to zero in the 2020 first quarter. The French authorities are considering that the existence of IP Suisse, a wholly-owned subsidiary of Interparfums SA, does not, in and of itself, constitute a permanent establishment and therefore Interparfums, SA should pay French taxes on all or part of the profits of that entity. The French Tax Authority notified the Company that IP Suisse will be the subject of a tax audit covering the period January 1, 2010 through December 31, 2018. No claim or assessment for any taxes or penalties has been made at this time. The Company disagrees and is prepared to vigorously defend its position. Consequently, no provision has been made in the accompanying consolidated financial statements as we believe it is more likely than not that our position will be sustained based on its technical merits. Although we believe that we have sufficient arguments to support our position, there exists a risk that the French authorities may prevail. The Company’s exposure in connection with this matter is approximately $5.8 million, net of recovery taxes already paid to the Swiss authorities and excluding interest. Page 22 INTER PARFUMS, INC. AND SUBSIDIARIES Other than as discussed above, we did not experience any significant changes in tax rates, and none were expected in jurisdictions where we operate. Net Income and Earnings per Share Three months ended March 31, (in thousands except per share data) 2021 2020 Net income attributable to European operations $ 32,439 $ 11,693 Net income attributable to United States operations 4,187 1,606 Net income 36,626 13,299 Less: Net income attributable to the noncontrolling interest 8,964 3,240 Net income attributable to Inter Parfums, Inc. $ 27,662 $ 10,059 Net income attributable to Inter Parfums, Inc. common shareholders: Basic $ 0.87 $ 0.32 Diluted $ 0.87 $ 0.32 Weighted average number of shares outstanding: Basic 31,631 31,530 Diluted 31,772 31,708 Net income increased 175.4% to $36.6 million for the three months ended March 31, 2021, as compared to $13.3 million for the corresponding period of the prior year. The reasons for significant fluctuations in net income for both European operations and United States operations are directly related to the previous discussions relating to changes in sales, gross margin, and selling, general and administrative expenses and effective tax rates. The noncontrolling interest arises primarily from our 73% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 27% of Interparfums SA shares trade on the NYSE Euronext. The noncontrolling interest is also affected by the profitability of Interparfums SA’s 51% owned distribution subsidiaries in Spain. Net income attributable to the noncontrolling interest aggregated 28% of European operations net income for both the three months ended March 31, 2021 and 2020. Net income attributable to Inter Parfums, Inc. increased 175.0% to $27.7 million, as compared to $10.1 million for the corresponding period of the prior year. Liquidity and Capital Resources Our conservative financial tradition has enabled us to amass hefty cash balances and nominal long-term debt. As of March 31, 2021 we had $294 million in cash, cash equivalents and short-term investments, most of which is held in euro by our European operations and is readily convertible into U.S. dollars. We have not had any liquidity issues to date, and do not expect any liquidity issues relating to such cash and cash equivalents and short-term investments held by our European operations. As of March 31, 2021 long-term debt aggregated only $9.2 million and we also have $49 million available in untapped credit facilities. As of March 31, 2021, working capital aggregated $462 million and we had a working capital ratio in excess of 4 to 1. Approximately 86% of the Company’s total assets are held by European operations, and approximately $179 million of trademarks, licenses and other intangible assets are held by European operations. Page 23 INTER PARFUMS, INC. AND SUBSIDIARIES The Company hopes to benefit from its strong financial position to potentially acquire one or more brands, either on a proprietary basis or as a licensee. Opportunities for external growth continue to be examined, with the priority of maintaining the quality and homogeneous nature of our portfolio. However, we cannot assure you that any new license or acquisition agreements will be consummated. Cash provided by operating activities aggregated $32.5 million for the three month period ended March 31, 2021, as compared to cash used in operating activities of $25.1 million for the three months ended March 31, 2020. For the 2021 period, working capital items used $12.9 million in cash from operating activities, as compared to $40.6 million in the 2020 period. Although accounts receivable is up 26% from year end, the balance is reasonable based on first quarter 2021 record sales levels and reflects strong collection activity as day’s sales outstanding is down to 71 for the 2021 period as compared to 85 days for the corresponding period of the prior year. Inventory levels are down 3% from year end and includes inventory anticipated to be needed to support 2021 new product launches. Cash flows used in investing activities in 2021 reflect the purchases of short-term investments. These investments are primarily certificates of deposit and other contracts with maturities greater than three months. At March 31, 2021, approximately $82 million of such certificates of deposit contain penalties where we would forfeit a portion of the interest earned in the event of early withdrawal. Our business is not capital intensive as we do not own any manufacturing facilities. On a full year basis, we expect to spend approximately $4.0 million on tools and molds, depending on our new product development calendar. Capital expenditures also include amounts for office fixtures, computer equipment and industrial equipment needed at our distribution centers. In April 2021, our majority owned Paris-based subsidiary, Interparfums SA, completed the acquisition of its future headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer, Apsys. This is an office complex combining three buildings connected by two inner courtyards, which consists of approximately 40,000 total sq. ft. The €125 million (approximately $149 million) purchase price for this building, is in line with market values, includes the complete renovation of the site and is financed by a 10-year €120 million (approximately $143 million) bank loan to take advantage of low current interest rates. In June 2020, the Company and Divabox, owner of the Origines-parfums e-commerce platform for beauty products, signed a strategic agreement and equity investment pursuant to which we acquired 25% of Divabox capital for $14 million through a capital increase. In connection with the acquisition, the Company entered into a $13.4 million term loan, which was repaid in full in February 2021. Effective January 1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, we have taken $2.4 million impairment charge on our Rochas fashion trademark. The remaining value of the Rochas fashion trademarks is €17.1 million (approximately $20.0 million). The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025, at its then fair market value. Page 24 INTER PARFUMS, INC. AND SUBSIDIARIES Our short-term financing requirements are expected to be met by available cash on hand at March 31, 2021, and short-term credit lines provided by domestic and foreign banks. The principal credit facilities for 2021 consist of a $20.0 million unsecured revolving line of credit provided by a domestic commercial bank, and approximately $29.3 million in credit lines provided by a consortium of international financial institutions. There were no short-term borrowings outstanding as of both March 31, 2021 and 2020. In October 2019, the Board of Directors authorized a 20% increase in the annual dividend to $1.32 per share. In April 2020, as a result of the uncertainties raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the quarterly cash dividend. In February 2021, our Board of Directors authorized a reinstatement of an annual dividend of $1.00, payable quarterly. The next quarterly cash dividend of $0.25 per share is payable on June 30, 2021 to shareholders of record on June 15, 2021. We believe that funds provided by or used in operations can be supplemented by our present cash position and available credit facilities, so that they will provide us with sufficient resources to meet all present and reasonably foreseeable future operating needs. Inflation rates in the U.S. and foreign countries in which we operate did not have a significant impact on operating results for the three months ended March 31, 2021. Item 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK General We address certain financial exposures through a controlled program of risk management that primarily consists of the use of derivative financial instruments. We primarily enter into foreign currency forward exchange contracts in order to reduce the effects of fluctuating foreign currency exchange rates. We do not engage in the trading of foreign currency forward exchange contracts or interest rate swaps. Foreign Exchange Risk Management We periodically enter into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and to manage risks related to future sales expected to be denominated in a currency other than our functional currency. We enter into these exchange contracts for periods consistent with our identified exposures. The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on the receivables and cash flows of Interparfums SA, whose functional currency is the euro. All foreign currency contracts are denominated in currencies of major industrial countries and are with large financial institutions, which are rated as strong investment grade. All derivative instruments are required to be reflected as either assets or liabilities in the balance sheet measured at fair value. Generally, increases or decreases in fair value of derivative instruments will be recognized as gains or losses in earnings in the period of change. If the derivative is designated and qualifies as a cash flow hedge, then the changes in fair value of the derivative instrument will be recorded in other comprehensive income. Page 25 INTER PARFUMS, INC. AND SUBSIDIARIES Before entering into a derivative transaction for hedging purposes, we determine that the change in the value of the derivative will effectively offset the change in the fair value of the hedged item from a movement in foreign currency rates. Then, we measure the effectiveness of each hedge throughout the hedged period. Any hedge ineffectiveness is recognized in the income statement. At March 31, 2021, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. $78.5 million and GB £2.7 million which all have maturities of less than one year. We believe that our risk of loss as the result of nonperformance by any of such financial institutions is remote. Interest Rate Risk Management We mitigate interest rate risk by monitoring interest rates, and then determining whether fixed interest rates should be swapped for floating rate debt, or if floating rate debt should be swapped for fixed rate debt. Item 4. CONTROLS AND PROCEDURES Evaluation of Disclosure Controls and Procedures Our Chief Executive Officer and Chief Financial Officer have reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rule 13a-15(e)) as of the end of the period covered by this quarterly report on Form 10-Q (the “Evaluation Date”). Based on their review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of the Evaluation Date, our Company’s disclosure controls and procedures were effective. Changes in Internal Control Over Financial Reporting There has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Securities Exchange Act of 1934) that occurred during the quarterly period covered by this report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. Part II. Other Information Items 1. Legal Proceedings, 1A. Risk Factors, 2. Unregistered Sales of Equity Securities and Use of Proceeds, 3. Defaults Upon Senior Securities, 4. Mine Safety Disclosures and 5. Other Information, are omitted as they are either not applicable or have been included in Part I. Page 26 INTER PARFUMS, INC. AND SUBSIDIARIES Item 6. Exhibits The following documents are filed herewith: Exhibit No. Description Page Number 31.1 Certifications required by Rule 13a-14(a) of Chief Executive Officer Page 29 31.2 Certifications required by Rule 13a-14(a) of Chief Financial Officer and Principal Accounting Officer Page 30 32.1 Certification required by Section 906 of the Sarbanes-Oxley Act of Chief Executive Officer Page 31 32.2 Certification required by Section 906 of the Sarbanes-Oxley Act of Chief Financial Officer and Principal Accounting Officer Page 32 101 Interactive data files Page 27 INTER PARFUMS, INC. AND SUBSIDIARIES SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on the 10th day of May 2021. INTER PARFUMS, INC. By: /s/ Russell Greenberg Executive Vice President and Chief Financial Officer Page 28